Table 3 Clinical Parameters of circRNAs in CRC
From: Prognostic and diagnostic value of circRNA expression in colorectal carcinoma: a meta-analysis
| Â | Tumor promoter | Tumor Suppressor | ||||
|---|---|---|---|---|---|---|
OR | 95%CI | P | OR | 95%CI | P | |
Age (older/younger) | 1.078 | 0.737–1.577 | 0.698 | 0.589 | 0.241–1.437 | 0.224 |
Gender (M/W) | 1.114 | 0.757–1.639 | 0.968 | 0.805 | 0.491–1.320 | 0.390 |
Tumor size (larger/smaller) | 1.769 | 1.097–2.852 | 0.019 | 0.658 | 0.382–1.132 | 0.131 |
Tumor location (rectum/colon) | 0.888 | 0.572–1.380 | 0.598 | 0.902 | 0.480–1.694 | 0.748 |
Differentiation grade (poor/well & moderate) | 1.743 | 1.032–2.946 | 0.038 | 0.453 | 0.261–0.787 | 0.005 |
TNM stage (III + IV/I + II) | 3.320 | 1.529–7.207 | 0.002 | 0.442 | 0.187–1.042 | 0.062 |
T classification (T3 + T4/T1 + T2) | 3.410 | 2.088–5.567 | 0.000 | 0.533 | 0.328–0.934 | 0.027 |
Lymph node metastasis (Y/N) | 3.357 | 2.160–5.215 | 0.000 | 0.389 | 0.116–1.307 | 0.127 |
Distant metastasis (Y/N) | 4.338 | 2.503–7.520 | 0.000 | 0.196 | 0.077–0.498 | 0.001 |